Table 2.
Frequency and severity of adverse drugs observed during MDR/RR-TB treatment
| Total (n = 35) |
HIV Negative (n = 11) |
HIV Positive (n = 24) |
p-value* | |
|---|---|---|---|---|
| N (%) | N (%) | N (%) | ||
| Adverse events | ||||
| No adverse events | 18 (51.4) | 9 (81.8) | 9 (37.5) | 0.027 |
| Adverse events | 17 (48.6) | 2 (18.2) | 15 (62.5) | |
| 1 event | 14 (82.4) | 2 (18.2) | 12 (50.0) | |
| ≥ 2 events | 3 (17.6) | - | 3 (12.5) | |
| TB regimen change | ||||
| No | 14 (40.0) | 5 (45.5) | 9 (37.5) | 0.656 |
| Yes | 21 (60.0) | 6 (54.5) | 15 (62.5) | |
TB Tuberculosis
P values from Chi-square or Fisher’s exact tests. Chi-squared, P < 0.05- statistically significant